Columbia Laboratories Inc (NASDAQ:CBRX)
| 0.6478 Data as of May 17 |  +0.0015 / +0.23%Today’s Change | 0.55 Today|||52-Week Range 1.23 | +1.94% Year-to-Date |
Latest CBRX News | Press Releases
No recent news for Columbia Laboratories Inc.
Today’s Trading
| Previous close | 0.65 |
| Today’s open | 0.63 |
| Day’s range | 0.63 - 0.65 |
| Volume | 260,538 |
| Average volume (3 months) | 267,419 |
| Market cap | $56.8M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -86.36% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -40.02% |
| P/E ratio | 16.2 |
| Price/Sales | 2.15 |
| Price/Book | 1.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Hubei Minkang Pharma... | 0.00 | 0.00% |
| DMPIDelMar Pharmaceutica... | +0.21 | +9.37% |
| TSPTTranscept Pharmaceut... | +0.07 | +2.27% |
| ATNMCactus Ventures Inc | -0.05 | -1.28% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.02 |
| Annual revenue (last year) | $25.8M |
| Annual profit (last year) | $9.9M |
| Net profit margin | 38.40% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Frank C. Condella, Jr., MBA |
Chief Financial Officer, Secretary, Treasurer & VP Jonathan B. Lloyd Jones, MBA |
Corporate headquarters Livingston, New Jersey |
Forecasts
